[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BE1002266A5 - Compositions de cyclosporine pour application topique. - Google Patents

Compositions de cyclosporine pour application topique. Download PDF

Info

Publication number
BE1002266A5
BE1002266A5 BE8900520A BE8900520A BE1002266A5 BE 1002266 A5 BE1002266 A5 BE 1002266A5 BE 8900520 A BE8900520 A BE 8900520A BE 8900520 A BE8900520 A BE 8900520A BE 1002266 A5 BE1002266 A5 BE 1002266A5
Authority
BE
Belgium
Prior art keywords
topical application
compositions
cyclosporin compositions
alcohol
cyclosporin
Prior art date
Application number
BE8900520A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888811357A external-priority patent/GB8811357D0/en
Priority claimed from GB888824779A external-priority patent/GB8824779D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1002266A5 publication Critical patent/BE1002266A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention a pour objet des compositions pharmaceutiques comprenant une cyclosporine, par exemple la Ciclosporine, et un acide ou un alcool gras mono- ou polyinsaturé, par exemple l'acide oléique ou l'alcool oléylique. Les compositions conviennent pour une application dermique, par exemple dans le traitement d'une maladie auto-immune de la peau pour favoriser la pousse des cheveux.
BE8900520A 1988-05-13 1989-05-12 Compositions de cyclosporine pour application topique. BE1002266A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888811357A GB8811357D0 (en) 1988-05-13 1988-05-13 Improvements in/relating to organic compounds
GB888824779A GB8824779D0 (en) 1988-10-21 1988-10-21 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
BE1002266A5 true BE1002266A5 (fr) 1990-11-13

Family

ID=26293884

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900520A BE1002266A5 (fr) 1988-05-13 1989-05-12 Compositions de cyclosporine pour application topique.

Country Status (8)

Country Link
US (1) US5807820A (fr)
JP (1) JPH075473B2 (fr)
BE (1) BE1002266A5 (fr)
CH (1) CH679119A5 (fr)
DE (2) DE3943838B4 (fr)
FR (1) FR2631235B1 (fr)
GB (1) GB2218334B (fr)
IT (1) IT1232832B (fr)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
ES2087165T3 (es) * 1989-11-30 1996-07-16 Croda Int Plc Uso de acido nervonico y de acidos grasos de cadenas largas en el tratamiento de las alteraciones provocadas por la desmielinizacion.
WO1992011036A1 (fr) * 1990-12-21 1992-07-09 Wade, Jonathan, Leslie Adjuvants comprenant des lipides insatures
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
IL102236A0 (en) * 1991-06-27 1993-01-14 Ltt Inst Co Ltd Topical preparations containing cyclosporin
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
AU688920B2 (en) * 1991-06-27 1998-03-19 Novartis Ag Transesterified corn oil products
US5378152A (en) * 1992-05-01 1995-01-03 Dental Marketing Specialists, Inc. Method and apparatus for installation of dental implant
EP0642332B1 (fr) 1992-05-13 1997-01-15 Sandoz Ltd. Compositions ophtalmiques contenant une cyclosporine
EP1142568A1 (fr) 1992-09-25 2001-10-10 Novartis AG Compositions pharmaceutiques à base de cyclosporines
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
JP2727053B2 (ja) * 1993-12-27 1998-03-11 東亜機工 株式会社 パンティライナーおよびその製造装置
EP0743846B1 (fr) * 1994-02-02 2000-10-04 The Procter & Gamble Company Compositions de soins pour les cheveux contenant un alcool gras a point de fusion peu eleve et un polymere d'oxyde d'ethylene/oxyde de propylene
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
DE19611953A1 (de) * 1996-03-26 1997-10-02 Beiersdorf Ag Verwendung von ungesättigten Monocarbonsäuren gegen Superinfektionen
CZ267796A3 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
NZ314060A (en) * 1997-01-13 1997-08-22 Bernard Charles Sherman Pharmaceutical microemulsion preconcentrate comprising cyclosporin dissolved in a solvent system comprising hydrophobic solvent(s) and surfactant(s)
BR9807528A (pt) 1997-01-30 2000-03-14 Novartis Ag Composições farmacêuticas isentas de óleo contendo ciclosporina a
TW592719B (en) * 1997-03-26 2004-06-21 Shiseido Co Ltd Hair growth phase extender composition containing unsaturated fatty acid and/or its derivatives or an extract of a plant belonging to the Coriandrum
EP0888773A1 (fr) * 1997-07-05 1999-01-07 Societe Des Produits Nestle S.A. Utilisation de l'acide pétrosélinique pour le traitement des inflammations des tissus superficiels
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6042841A (en) * 1998-03-16 2000-03-28 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Cosmetic method of treating skin
US6022896A (en) * 1998-09-10 2000-02-08 Chesebrough-Pond's Usa Co. Petroselinic acid as an anti-irritant in compositions containing alpha-hydroxy acids
FR2782638B1 (fr) * 1998-08-28 2003-04-11 Shiseido Internat France S A S Utilisation en cosmetique d'acides gras
US6288112B1 (en) 1998-11-20 2001-09-11 The General Hospital Corporation Use of pyrethroid compounds to promote hair growth
US6638522B1 (en) 1998-12-11 2003-10-28 Pharmasolutions, Inc. Microemulsion concentrate composition of cyclosporin
PT1091750E (pt) 1999-02-26 2009-11-10 Maas Biolab Llc Composição farmacêutica cerebroespinal e vascular e processo para a sua preparação
AU3861900A (en) * 1999-03-05 2000-09-21 University Of Texas Southwestern Medical Center, The Method of treating hair loss using non-immunosuppressive compounds
US6057289A (en) * 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
AU3712100A (en) 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Method of treating hair loss using sulfonyl thyromimetic compounds
US6521595B1 (en) * 1999-11-19 2003-02-18 Lg Chemical, Ltd. Nonimmunosuppressive [γ-hydroxy-methylleucine4] cyclosporin A, hair growth stimulator and external composition for skin using the same
AU1420801A (en) * 1999-11-19 2001-05-30 Lg Household & Health Care Ltd. Use of nonimmunosuppressive cyclosporin derivatives for hair growth
DE10053328A1 (de) * 2000-10-27 2002-05-08 Cognis Deutschland Gmbh Kosmetische Zubereitungen
KR100360716B1 (ko) * 2000-11-22 2002-11-13 주식회사 엘지생활건강 사이클로스포린 에이 7- 티오아미드 유도체를유효성분으로 하는 모발성장촉진제
KR20020039528A (ko) * 2000-11-22 2002-05-27 조명재 사이클로스포린 7- 티오아미드 유도체를 유효성분으로하는 모발성장촉진제
KR20020050135A (ko) * 2000-12-20 2002-06-26 조명재 피부 주름 예방 및 완화를 목적으로 하는 피부 외용 조성물
KR100681670B1 (ko) * 2001-02-14 2007-02-09 주식회사 엘지생활건강 [감마 히드록시 엔- 메틸-엘-루신9]사이클로스포린 에이를유효성분으로 하는 모발 성장 촉진제
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
KR100465012B1 (ko) * 2001-05-11 2005-01-13 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
KR100695610B1 (ko) * 2001-05-15 2007-03-14 주식회사 엘지생활건강 비면역성 발모성분인 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린 유도체를 함유한 두피 및 경피용 제제 조성물
KR100695611B1 (ko) * 2001-05-17 2007-03-14 주식회사 엘지생활건강 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린유도체를 유효성분으로 하는 모발 성장 촉진제
AU2002231703B2 (en) 2001-12-14 2007-03-29 Jagotec Ag Pharmaceutical formulation comprising cyclosporin and use thereof
US6987090B2 (en) 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
ZA200502613B (en) * 2002-10-10 2006-10-25 Yeda Res & Dev Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
KR100439467B1 (ko) * 2002-11-13 2004-07-09 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
WO2004071398A2 (fr) * 2003-02-17 2004-08-26 Cipla Ltd Composition pharmaceutique
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
GB0413730D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
GB0413729D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
IL181217A0 (en) * 2007-02-08 2007-07-04 Haim Levy Pharmaceuticalcompositions based on a microemulsion
WO2008106091A1 (fr) * 2007-02-26 2008-09-04 Yeda Research And Development Co. Ltd. Utilisation de dérivés d'alcool à longue chaîne pour le traitement de l'alopécie aerata
WO2008106092A1 (fr) * 2007-02-26 2008-09-04 Yeda Research And Development Co. Ltd. Énantiomères d'ester octadéc-9-(z)énylique d'acide amino-phényl-acétique, leurs sels et leurs utilisations
CA2697756A1 (fr) * 2007-09-10 2009-03-19 Maruho Co., Ltd. Composition pharmaceutique de type emulsion de cristaux liquides contenant de la cyclosporine et procede de traitement d'une maladie de la peau par celle-ci
TW200932240A (en) * 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
WO2021134028A1 (fr) * 2019-12-24 2021-07-01 Ampersand Biopharmaceuticals, Inc. Cyclosporine topique pour le traitement du psoriasis et d'autres maladies

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127426A1 (fr) * 1983-05-23 1984-12-05 Takeda Chemical Industries, Ltd. Compositions pharmaceutiques percutanées pour application externe
EP0171742A2 (fr) * 1984-08-10 1986-02-19 E.I. Du Pont De Nemours And Company Administration transdermale de dérivés opiacés
WO1987006463A1 (fr) * 1986-05-02 1987-11-05 Brigham And Women's Hospital Composition a faible nephrotoxicite comprenant un composant contenant un acide gras et de la cyclocporine

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2528516A1 (de) * 1974-07-05 1976-01-22 Sandoz Ag Neue galenische zubereitung
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
CA1165240A (fr) * 1980-07-09 1984-04-10 The Procter & Gamble Company Composes pharmaceutiques a usage topique
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
JPS6097544A (ja) * 1983-11-01 1985-05-31 Casio Comput Co Ltd 薄型電池
CH667274A5 (de) * 1984-03-23 1988-09-30 Sandoz Ag Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
JPS61280435A (ja) * 1985-04-04 1986-12-11 Kanji Takada サイクロスポリン類のリンパ指向性製剤
JPS61249918A (ja) * 1985-04-26 1986-11-07 Yutaka Mizushima 点眼剤
DE3531597A1 (de) * 1985-09-04 1987-03-05 Bioferon Biochem Substanz Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung psoriatischer erkrankungen
ZA875317B (en) * 1986-08-01 1988-01-25 Warner-Lambert Company Transdermal compositions
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
GB2206119B (en) * 1987-06-22 1990-10-31 Merck & Co Inc A new cyclosporin derivative with modified "8-amino acid"
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US4970016A (en) * 1987-09-29 1990-11-13 Colgate-Palmolive Co. Thixotropic aqueous liquid automatic dishwashing detergent composition
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127426A1 (fr) * 1983-05-23 1984-12-05 Takeda Chemical Industries, Ltd. Compositions pharmaceutiques percutanées pour application externe
EP0171742A2 (fr) * 1984-08-10 1986-02-19 E.I. Du Pont De Nemours And Company Administration transdermale de dérivés opiacés
WO1987006463A1 (fr) * 1986-05-02 1987-11-05 Brigham And Women's Hospital Composition a faible nephrotoxicite comprenant un composant contenant un acide gras et de la cyclocporine

Also Published As

Publication number Publication date
DE3943838B4 (de) 2009-06-25
GB2218334A (en) 1989-11-15
GB2218334B (en) 1991-10-02
JPH075473B2 (ja) 1995-01-25
JPH0217127A (ja) 1990-01-22
DE3915617A1 (de) 1989-11-16
CH679119A5 (fr) 1991-12-31
US5807820A (en) 1998-09-15
DE3915617B4 (de) 2007-01-18
IT8947949A0 (it) 1989-05-12
FR2631235A1 (fr) 1989-11-17
IT1232832B (it) 1992-03-05
FR2631235B1 (fr) 1994-04-29
GB8910707D0 (en) 1989-06-28

Similar Documents

Publication Publication Date Title
BE1002266A5 (fr) Compositions de cyclosporine pour application topique.
US8158161B2 (en) Methods and pharmaceutical compositions useful for treating psoriasis
AU707028B2 (en) Use,in a composition, of an extract of at least one labiate
FR2637182A1 (fr) Compositions a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un ecdysteroide, de preference l'ecdysterone, ou l'un de ses derives; et compositions cosmetiques, pharmaceutiques, notamment dermatologiques, de sericulture ou phytosanitaires l'incorporant
JP3513873B2 (ja) 皮膚外用剤
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
US20080038208A1 (en) Pharmaceutical/cosmetic compositions comprising the lysine-d-proline-valine tripeptide
FR2788058A1 (fr) Compositions cosmetiques amincissantes
BE1002665A4 (fr) Nouvelle forme cristalline de la ciclosporine, sa preparation et les compositions pharmaceutiques la contenant.
JPH1072336A (ja) コラーゲンゲル収縮促進剤
KR20010023533A (ko) 피부과용 조성물
FR2385403A1 (fr) Nouvelles compositions diagnostiques radio-actives contenant de l'albumine et leur procede de preparation
O'FARRELL Pityriasis alba
AU3768789A (en) Cosmetic and skin treatment compositions
FR2446634A1 (fr) Composition a base d'hydrolysat de lactalbumine pour le traitement et les soins de la peau
US3395236A (en) Composition comprising oleic acid, polyethylene glycol, and gelating for treating nail infections
ATE302594T1 (de) Zubereitungen zur aknebehandlung
EP1611898B9 (fr) Composition permettant de prevenir et de traiter la cellulite
BE900012A (fr) Nouveau peptide.
EP0138720A3 (fr) Nouveaux benzenesulfonamides n-cyclises, leur procédé de préparation et leur utilisation comme substance active de compositions pharmaceutiques
BE1002504A3 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
RU99107658A (ru) Применение белков в качестве агентов против аутоиммунных заболеваний
JPS60243008A (ja) 発毛養毛剤
GB2137495A (en) Anti-acne composition
JPH06183932A (ja) 養毛化粧料

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20090512